Copy Number Variations of EphA3 Are Associated With Multiple Types of Hematologic Malignancies
- 1 February 2011
- journal article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 11 (1), 50-53
- https://doi.org/10.3816/clml.2011.n.006
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Low frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma.Neoplasma, 2009
- The EphA3 receptor is expressed in a subset of rhabdomyosarcoma cell lines and suppresses cell adhesion and migrationJournal of Cellular Biochemistry, 2008
- Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell linesBiochemical and Biophysical Research Communications, 2006
- EphB/EphrinB Receptors and Wnt Signaling in Colorectal CancerCancer Research, 2006
- The role of ephrins and Eph receptors in cancerCytokine & Growth Factor Reviews, 2004
- EphA3 is induced by CD28 and IGF-1 and regulates cell adhesionExperimental Cell Research, 2003
- Eph receptors and ephrin ligands: embryogenesis to tumorigenesisOncogene, 2000
- Cloning and Characterization of EphA3 (Hek) Gene Promoter: DNA Methylation Regulates Expression in Hematopoietic Tumor CellsBlood, 1999
- Unified Nomenclature for Eph Family Receptors and Their Ligands, the EphrinsCell, 1997
- Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell lines.Proceedings of the National Academy of Sciences of the United States of America, 1992